CVU receptor — Drug Target
All drugs that target CVU receptor — marketed and clinical-stage.
Phase 3 pipeline (1)
- allo-APZ2-CVU · RHEACELL GmbH & Co. KG
Allo-APZ2-CVU is a small molecule that targets the CVU receptor.
All drugs that target CVU receptor — marketed and clinical-stage.